
1. proc natl acad sci u a. 2019 sep 17;116(38):19109-19115. doi:
10.1073/pnas.1904732116. epub 2019 aug 28.

cryo-em structure pleconaril-resistant rhinovirus-b5 complexed the
antiviral obr-5-340 reveals unexpected binding site.

wald j(1)(2)(3), pasin m(4), richter m(5), walther c(5), mathai n(6)(7)(8),
kirchmair j(6)(7)(8), makarov va(9), goessweiner-mohr n(10), marlovits
tc(1)(2)(3), zanella i(4), real-hohn a(4), verdaguer n(11), blaas d(12),
schmidtke m(13).

author information: 
(1)centre structural systems biology (cssb), d-22607 hamburg, germany.
(2)institute structural systems biology, university medical center
hamburg-eppendorf, d-22607 hamburg, germany.
(3)german electron synchrotron centre (desy), d-22607 hamburg, germany.
(4)department medical biochemistry, max f. perutz laboratories, vienna
biocenter, medical university vienna, a-1030 vienna, austria.
(5)department medical microbiology, section experimental virology, jena
university hospital, d-07740 jena, germany.
(6)department chemistry, university bergen, n-5020 bergen, norway.
(7)computational biology unit (cbu), university bergen, n-5020 bergen, norway.
(8)center bioinformatics (zbh), universit채t hamburg, d-20146 hamburg,
germany.
(9)laboratory biomedicinal chemistry, institute biochemistry, federal
research center fundamentals biotechnology russian academy sciences, 119071
moscow, russia.
(10)institute biophysics, johannes kepler university linz, a-4020 linz,
austria.
(11)structural biology unit, institute molecular biology barcelona, spanish
research council, e-08028 barcelona, spain.
(12)department medical biochemistry, max f. perutz laboratories, vienna
biocenter, medical university vienna, a-1030 vienna, austria;
dieter.blaas@meduniwien.ac.at michaela.schmidtke@med.uni-jena.de.
(13)department medical microbiology, section experimental virology, jena
university hospital, d-07740 jena, germany; dieter.blaas@meduniwien.ac.at
michaela.schmidtke@med.uni-jena.de.

viral inhibitors, pleconaril vapendavir, target conserved regions 
the capsids rhinoviruses (rvs) enteroviruses (evs) binding a
hydrophobic pocket viral capsid protein 1 (vp1). resistant rvs evs,
bulky residues pocket prevent binding. however, recently developed 
pyrazolopyrimidines inhibit pleconaril-resistant rvs evs, computational
modeling suggested also bind hydrophobic pocket vp1. we
studied mechanism inhibition pleconaril-resistant rvs using rv-b5 (1 of
the 7 naturally pleconaril-resistant rhinoviruses) obr-5-340, bioavailable 
pyrazolopyrimidine proven vivo activity, determined 3d-structure 
of protein-ligand complex 3.6 책 cryoelectron microscopy. data
indicate that, similar capsid binders, obr-5-340 induces thermostability
and inhibits viral adsorption uncoating. however, found obr-5-340
attaches closer entrance pocket capsid binders,
whose viral complexes studied far, showing marginal overlaps of
the attachment sites. comparing experimentally determined 3d structure with
the control, rv-b5 incubated solvent determined 3.2 책, revealed 
no gross conformational changes upon obr-5-340 binding. pocket the
naturally obr-5-340-resistant rv-a89 likewise incubated obr-5-340 solved
to 2.9 책 empty. pyrazolopyrimidines rigid molecular scaffold may
thus less affected loss entropy upon binding. interact with
less-conserved regions known capsid binders. overall, pyrazolopyrimidines
could suitable development new, broadly active inhibitors.

doi: 10.1073/pnas.1904732116 
pmcid: pmc6754595
pmid: 31462495  [indexed medline]

conflict interest statement: authors declare conflict interest.

